The expression and clinicobiological significance of Survivin in Dukes'C stage colorectal cancer

Chinese Journal of Clinical Oncology

Volumn 32, Issue 17, 2005, Pages 979-983

  Song, Yucheng ^a   Wan, Desen ^a   Pan, Zhizhong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Adjuvant chemotherapy; Colorectal cancer; Dukes'C stage; Survivin

Indexed keywords

ANTINEOPLASTIC AGENT; SURVIVIN;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER INFILTRATION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT RESPONSE;

EID: 35748946653     PISSN: 16727118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chinese source
2. Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, 5-fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].N Engl J Med, 2004, 350(23):2343-2351
3. Kawasaki H, Altieri DC, Lu CD, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer [J]. Cancer Res, 1998, 58(22):5071-5074
4. Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7[J]. Biochemistry, 2001, 40(4):1117-1123
5. Suzuki A, Ito T, Kawano H, et al. Survivin initiates procaspase-3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death [J]. Oncogene, 2000, 19 (10):1346-1353
6. Zaffaroni N, Pennati M, Colella G, et al. Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer [J]. Cell Mol Life Sci, 2002, 59(8):1406-1412
7. Nakamura M, Tsuji N, Asanuma K, et al. Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients [J]. Cancer Sci, 2004, 95(1): 44-51
8. Kato J, Kuwababa Y, Mitani M, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy [J]. Int J Cancer, 2001, 95(2):92-95
9. Olie RA, Simoes-Wust AP, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy [J]. Cancer Res, 2000, 60(11):2805-2809
10. Yamamoto T, Manome Y, Nakamura M, et al. Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer [J]. Eur J Cancer, 2002, 38(17):2316-2324
11. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling [J]. Cell, 2000,103(2):311-320
12. Kim PJ, Plescia J, Clevers H, et al. Survivin and molecular pathogenesis of colorectal cancer [J]. Lancent, 2003, 362 (9379): 205-209
13. Kawasaki H, Toyoda M, Shinohara H, et al. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis [J]. Cancer, 2001, 91(11): 2026-2032
14. Graf W, Pahlman L, Bergstrom R, et al. The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer [J]. Br J Cancer, 1994, 70(13):559-563